<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>DEALSCOPE ‚Äî Multi-Agent Reasoning</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&family=Fraunces:opsz,wght@9..144,400;9..144,600&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --white: #ffffff;
            --gray-50: #f8fafc;
            --gray-100: #f1f5f9;
            --gray-200: #e2e8f0;
            --gray-300: #cbd5e1;
            --gray-400: #94a3b8;
            --gray-500: #64748b;
            --gray-600: #475569;
            --gray-700: #334155;
            --gray-800: #1e293b;
            --gray-900: #0f172a;
            --teal: #0d9488;
            --teal-light: #14b8a6;
            --amber: #d97706;
            --red: #dc2626;
            --green: #16a34a;
            --blue: #2563eb;
            --purple: #7c3aed;
        }

        body {
            font-family: 'Inter', sans-serif;
            background: var(--gray-50);
            color: var(--gray-800);
            min-height: 100vh;
        }

        /* Top Bar */
        .topbar {
            display: flex;
            align-items: center;
            justify-content: space-between;
            padding: 1rem 2rem;
            background: var(--white);
            border-bottom: 1px solid var(--gray-200);
        }

        .topbar-left {
            display: flex;
            align-items: center;
            gap: 1.5rem;
        }

        .back-link {
            color: var(--gray-500);
            text-decoration: none;
            font-size: 0.9rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .deal-info h1 {
            font-size: 1.1rem;
            font-weight: 600;
        }

        .deal-info span {
            font-size: 0.85rem;
            color: var(--gray-500);
        }

        .live-badge {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            background: #dcfce7;
            color: var(--green);
            padding: 0.4rem 0.75rem;
            border-radius: 20px;
            font-size: 0.8rem;
            font-weight: 600;
        }

        .live-badge::before {
            content: '';
            width: 8px;
            height: 8px;
            background: var(--green);
            border-radius: 50%;
            animation: pulse 1.5s infinite;
        }

        @keyframes pulse {
            0%, 100% { opacity: 1; }
            50% { opacity: 0.4; }
        }

        /* Main Layout */
        .main-layout {
            display: grid;
            grid-template-columns: 300px 1fr 380px;
            min-height: calc(100vh - 65px);
        }

        /* Left: Agent Status Panel */
        .agent-panel {
            background: var(--white);
            border-right: 1px solid var(--gray-200);
            padding: 1.5rem;
        }

        .panel-title {
            font-size: 0.75rem;
            font-weight: 600;
            color: var(--gray-500);
            text-transform: uppercase;
            letter-spacing: 0.1em;
            margin-bottom: 1rem;
        }

        .agent-list {
            display: flex;
            flex-direction: column;
            gap: 0.75rem;
        }

        .agent-item {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 0.75rem;
            background: var(--gray-50);
            border-radius: 10px;
            cursor: pointer;
            transition: all 0.2s;
            border: 2px solid transparent;
        }

        .agent-item:hover {
            background: var(--gray-100);
        }

        .agent-item.active {
            border-color: var(--teal);
            background: #f0fdfa;
        }

        .agent-item.speaking {
            border-color: var(--amber);
            background: #fffbeb;
        }

        .agent-avatar {
            width: 36px;
            height: 36px;
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1rem;
        }

        .agent-avatar.contract { background: #dbeafe; }
        .agent-avatar.risk { background: #fef3c7; }
        .agent-avatar.financial { background: #d1fae5; }
        .agent-avatar.research { background: #e0e7ff; }
        .agent-avatar.compliance { background: #fce7f3; }
        .agent-avatar.legal { background: #f3e8ff; }
        .agent-avatar.comparables { background: #cffafe; }
        .agent-avatar.orchestrator { background: linear-gradient(135deg, var(--teal) 0%, var(--teal-light) 100%); color: white; }

        .agent-info {
            flex: 1;
        }

        .agent-name {
            font-size: 0.85rem;
            font-weight: 600;
            color: var(--gray-800);
        }

        .agent-status {
            font-size: 0.75rem;
            color: var(--gray-500);
        }

        .agent-indicator {
            width: 8px;
            height: 8px;
            border-radius: 50%;
        }

        .agent-indicator.active { background: var(--green); }
        .agent-indicator.thinking { background: var(--amber); animation: pulse 1s infinite; }
        .agent-indicator.idle { background: var(--gray-300); }

        /* Stats */
        .agent-stats {
            margin-top: 2rem;
            padding-top: 1.5rem;
            border-top: 1px solid var(--gray-200);
        }

        .stat-item {
            display: flex;
            justify-content: space-between;
            padding: 0.5rem 0;
        }

        .stat-label {
            font-size: 0.85rem;
            color: var(--gray-500);
        }

        .stat-value {
            font-family: 'JetBrains Mono', monospace;
            font-size: 0.85rem;
            font-weight: 600;
        }

        /* Center: Reasoning Canvas */
        .reasoning-canvas {
            padding: 2rem;
            overflow-y: auto;
        }

        .canvas-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 1.5rem;
        }

        .canvas-title {
            font-size: 1.1rem;
            font-weight: 600;
        }

        .canvas-controls {
            display: flex;
            gap: 0.5rem;
        }

        .control-btn {
            background: var(--white);
            border: 1px solid var(--gray-300);
            padding: 0.5rem 1rem;
            font-size: 0.8rem;
            border-radius: 6px;
            cursor: pointer;
            color: var(--gray-600);
        }

        .control-btn.active {
            background: var(--gray-900);
            color: var(--white);
            border-color: var(--gray-900);
        }

        /* Reasoning Thread */
        .reasoning-thread {
            display: flex;
            flex-direction: column;
            gap: 1rem;
        }

        .thread-item {
            display: flex;
            gap: 1rem;
            animation: slideIn 0.3s ease-out;
        }

        @keyframes slideIn {
            from {
                opacity: 0;
                transform: translateX(-20px);
            }
            to {
                opacity: 1;
                transform: translateX(0);
            }
        }

        .thread-avatar {
            width: 40px;
            height: 40px;
            border-radius: 12px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.1rem;
            flex-shrink: 0;
        }

        .thread-content {
            flex: 1;
            background: var(--white);
            border: 1px solid var(--gray-200);
            border-radius: 12px;
            padding: 1rem 1.25rem;
        }

        .thread-content.highlight {
            border-color: var(--teal);
            background: #f0fdfa;
        }

        .thread-content.warning {
            border-color: var(--amber);
            background: #fffbeb;
        }

        .thread-content.critical {
            border-color: var(--red);
            background: #fef2f2;
        }

        .thread-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.5rem;
        }

        .thread-agent {
            font-weight: 600;
            font-size: 0.9rem;
            color: var(--gray-800);
        }

        .thread-time {
            font-size: 0.75rem;
            color: var(--gray-400);
        }

        .thread-action {
            font-size: 0.75rem;
            color: var(--teal);
            background: #f0fdfa;
            padding: 0.2rem 0.5rem;
            border-radius: 4px;
            margin-bottom: 0.75rem;
            display: inline-block;
        }

        .thread-text {
            font-size: 0.9rem;
            line-height: 1.7;
            color: var(--gray-700);
        }

        .thread-text strong {
            color: var(--gray-900);
        }

        .thread-text code {
            font-family: 'JetBrains Mono', monospace;
            background: var(--gray-100);
            padding: 0.1rem 0.4rem;
            border-radius: 4px;
            font-size: 0.85rem;
        }

        /* Evidence Cards */
        .evidence-card {
            background: var(--gray-50);
            border: 1px solid var(--gray-200);
            border-radius: 8px;
            padding: 0.75rem 1rem;
            margin-top: 0.75rem;
            font-size: 0.8rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--gray-500);
            margin-bottom: 0.5rem;
        }

        .evidence-source {
            color: var(--teal);
            font-weight: 500;
            cursor: pointer;
        }

        .evidence-quote {
            color: var(--gray-600);
            font-style: italic;
            padding-left: 0.75rem;
            border-left: 2px solid var(--gray-300);
        }

        /* Handoff Indicator */
        .handoff {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 0.75rem 1rem;
            background: var(--gray-100);
            border-radius: 8px;
            margin: 0.5rem 0 0.5rem 3rem;
            font-size: 0.8rem;
            color: var(--gray-500);
        }

        .handoff-arrow {
            color: var(--teal);
            font-weight: 600;
        }

        /* Debate Section */
        .debate-section {
            margin-top: 1rem;
            padding: 1rem;
            background: linear-gradient(135deg, #fef3c7 0%, #fffbeb 100%);
            border: 1px solid #fcd34d;
            border-radius: 10px;
        }

        .debate-header {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            font-size: 0.8rem;
            font-weight: 600;
            color: var(--amber);
            margin-bottom: 0.75rem;
        }

        .debate-item {
            padding: 0.5rem 0;
            font-size: 0.85rem;
            border-bottom: 1px dashed rgba(217, 119, 6, 0.3);
        }

        .debate-item:last-child {
            border-bottom: none;
        }

        .debate-agent {
            font-weight: 600;
            color: var(--gray-700);
        }

        /* Consensus Box */
        .consensus-box {
            background: linear-gradient(135deg, #d1fae5 0%, #ecfdf5 100%);
            border: 2px solid var(--green);
            border-radius: 12px;
            padding: 1.25rem;
            margin-top: 1rem;
        }

        .consensus-header {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            font-weight: 600;
            color: var(--green);
            margin-bottom: 0.75rem;
        }

        .consensus-content {
            font-size: 0.9rem;
            color: var(--gray-700);
            line-height: 1.6;
        }

        .consensus-confidence {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            margin-top: 1rem;
            padding-top: 0.75rem;
            border-top: 1px solid rgba(22, 163, 74, 0.3);
        }

        .confidence-bar {
            flex: 1;
            height: 6px;
            background: rgba(22, 163, 74, 0.2);
            border-radius: 3px;
            overflow: hidden;
        }

        .confidence-fill {
            height: 100%;
            background: var(--green);
            border-radius: 3px;
        }

        .confidence-value {
            font-family: 'JetBrains Mono', monospace;
            font-size: 0.85rem;
            font-weight: 600;
            color: var(--green);
        }

        /* Right: Question Panel */
        .question-panel {
            background: var(--white);
            border-left: 1px solid var(--gray-200);
            display: flex;
            flex-direction: column;
        }

        .question-header {
            padding: 1.5rem;
            border-bottom: 1px solid var(--gray-100);
        }

        .question-header h3 {
            font-size: 1rem;
            font-weight: 600;
            margin-bottom: 0.25rem;
        }

        .question-header p {
            font-size: 0.8rem;
            color: var(--gray-500);
        }

        /* Sample Questions */
        .sample-questions {
            padding: 1rem 1.5rem;
            border-bottom: 1px solid var(--gray-100);
        }

        .sample-label {
            font-size: 0.7rem;
            color: var(--gray-400);
            text-transform: uppercase;
            letter-spacing: 0.1em;
            margin-bottom: 0.75rem;
        }

        .sample-btn {
            display: block;
            width: 100%;
            text-align: left;
            background: var(--gray-50);
            border: 1px solid var(--gray-200);
            border-radius: 8px;
            padding: 0.75rem;
            font-size: 0.85rem;
            color: var(--gray-600);
            cursor: pointer;
            margin-bottom: 0.5rem;
            transition: all 0.2s;
        }

        .sample-btn:hover {
            border-color: var(--teal);
            background: #f0fdfa;
            color: var(--teal);
        }

        /* Answer History */
        .answer-history {
            flex: 1;
            padding: 1.5rem;
            overflow-y: auto;
        }

        .answer-item {
            margin-bottom: 1.5rem;
        }

        .answer-question {
            font-size: 0.9rem;
            font-weight: 600;
            color: var(--gray-800);
            margin-bottom: 0.75rem;
        }

        .answer-content {
            background: var(--gray-50);
            border-radius: 10px;
            padding: 1rem;
            font-size: 0.85rem;
            color: var(--gray-600);
            line-height: 1.7;
        }

        .answer-meta {
            display: flex;
            gap: 1rem;
            margin-top: 0.75rem;
            font-size: 0.75rem;
            color: var(--gray-400);
        }

        /* Question Input */
        .question-input-area {
            padding: 1rem 1.5rem;
            border-top: 1px solid var(--gray-100);
        }

        .question-input {
            display: flex;
            gap: 0.75rem;
            background: var(--gray-50);
            border: 1px solid var(--gray-200);
            border-radius: 10px;
            padding: 0.75rem;
        }

        .question-input input {
            flex: 1;
            border: none;
            background: none;
            font-size: 0.9rem;
            outline: none;
        }

        .question-input input::placeholder {
            color: var(--gray-400);
        }

        .question-submit {
            background: var(--teal);
            color: white;
            border: none;
            width: 36px;
            height: 36px;
            border-radius: 8px;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: center;
        }
    </style>
</head>
<body>
    <div class="topbar">
        <div class="topbar-left">
            <a href="#" class="back-link">‚Üê Back to Deal</a>
            <div class="deal-info">
                <h1>NovaPharma Acquisition</h1>
                <span>$890M ‚Ä¢ Healthcare / Biotech</span>
            </div>
        </div>
        <div class="live-badge">Agents Active</div>
    </div>

    <div class="main-layout">
        <!-- Left: Agent Panel -->
        <aside class="agent-panel">
            <div class="panel-title">Active Agents (8)</div>
            <div class="agent-list">
                <div class="agent-item active">
                    <div class="agent-avatar orchestrator">üéØ</div>
                    <div class="agent-info">
                        <div class="agent-name">Orchestrator</div>
                        <div class="agent-status">Coordinating</div>
                    </div>
                    <div class="agent-indicator active"></div>
                </div>
                <div class="agent-item speaking">
                    <div class="agent-avatar contract">üìÑ</div>
                    <div class="agent-info">
                        <div class="agent-name">Contract Analyst</div>
                        <div class="agent-status">Analyzing ¬ß7.3...</div>
                    </div>
                    <div class="agent-indicator thinking"></div>
                </div>
                <div class="agent-item">
                    <div class="agent-avatar risk">‚ö†Ô∏è</div>
                    <div class="agent-info">
                        <div class="agent-name">Risk Assessor</div>
                        <div class="agent-status">Waiting for input</div>
                    </div>
                    <div class="agent-indicator active"></div>
                </div>
                <div class="agent-item">
                    <div class="agent-avatar financial">üí∞</div>
                    <div class="agent-info">
                        <div class="agent-name">Financial Modeler</div>
                        <div class="agent-status">Scenario ready</div>
                    </div>
                    <div class="agent-indicator active"></div>
                </div>
                <div class="agent-item">
                    <div class="agent-avatar research">üîç</div>
                    <div class="agent-info">
                        <div class="agent-name">Researcher</div>
                        <div class="agent-status">Idle</div>
                    </div>
                    <div class="agent-indicator idle"></div>
                </div>
                <div class="agent-item">
                    <div class="agent-avatar compliance">‚úÖ</div>
                    <div class="agent-info">
                        <div class="agent-name">Compliance</div>
                        <div class="agent-status">Idle</div>
                    </div>
                    <div class="agent-indicator idle"></div>
                </div>
                <div class="agent-item">
                    <div class="agent-avatar legal">‚öñÔ∏è</div>
                    <div class="agent-info">
                        <div class="agent-name">Legal RAG</div>
                        <div class="agent-status">Idle</div>
                    </div>
                    <div class="agent-indicator idle"></div>
                </div>
                <div class="agent-item">
                    <div class="agent-avatar comparables">üìä</div>
                    <div class="agent-info">
                        <div class="agent-name">Comparables</div>
                        <div class="agent-status">Idle</div>
                    </div>
                    <div class="agent-indicator idle"></div>
                </div>
            </div>

            <div class="agent-stats">
                <div class="panel-title">Session Stats</div>
                <div class="stat-item">
                    <span class="stat-label">Messages</span>
                    <span class="stat-value">47</span>
                </div>
                <div class="stat-item">
                    <span class="stat-label">Documents Cited</span>
                    <span class="stat-value">23</span>
                </div>
                <div class="stat-item">
                    <span class="stat-label">Findings</span>
                    <span class="stat-value">12</span>
                </div>
                <div class="stat-item">
                    <span class="stat-label">Debates Resolved</span>
                    <span class="stat-value">3</span>
                </div>
            </div>
        </aside>

        <!-- Center: Reasoning Canvas -->
        <main class="reasoning-canvas">
            <div class="canvas-header">
                <h2 class="canvas-title">Reasoning Thread: Change of Control Analysis</h2>
                <div class="canvas-controls">
                    <button class="control-btn active">Live</button>
                    <button class="control-btn">Condensed</button>
                    <button class="control-btn">Export</button>
                </div>
            </div>

            <div class="reasoning-thread">
                <!-- Orchestrator initiates -->
                <div class="thread-item">
                    <div class="thread-avatar" style="background: linear-gradient(135deg, var(--teal) 0%, var(--teal-light) 100%); color: white;">üéØ</div>
                    <div class="thread-content">
                        <div class="thread-header">
                            <span class="thread-agent">Orchestrator</span>
                            <span class="thread-time">2 min ago</span>
                        </div>
                        <span class="thread-action">TASK ASSIGNED</span>
                        <div class="thread-text">
                            <strong>Priority Task:</strong> Analyze all change-of-control provisions across licensing agreements. This is critical path for deal close. Assigning to Contract Analyst.
                        </div>
                    </div>
                </div>

                <div class="handoff">
                    <span class="handoff-arrow">‚Üí</span>
                    Handoff to Contract Analyst
                </div>

                <!-- Contract Analyst responds -->
                <div class="thread-item">
                    <div class="thread-avatar contract">üìÑ</div>
                    <div class="thread-content warning">
                        <div class="thread-header">
                            <span class="thread-agent">Contract Analyst</span>
                            <span class="thread-time">1 min ago</span>
                        </div>
                        <span class="thread-action">FINDING</span>
                        <div class="thread-text">
                            Found <strong>critical change-of-control clause</strong> in Pfizer License Agreement, Section 7.3:
                            <br><br>
                            The clause states consent <code>"may be withheld in Licensor's sole discretion"</code> ‚Äî this is the most restrictive standard. Pfizer has complete veto power over any acquisition.
                        </div>
                        <div class="evidence-card">
                            <div class="evidence-header">
                                üìÑ <span class="evidence-source">Pfizer_License_Agreement.pdf</span> ‚Ä¢ Page 34, ¬ß7.3
                            </div>
                            <div class="evidence-quote">
                                "...this Agreement and all rights and licenses granted hereunder shall automatically terminate unless Licensor provides its prior written consent to such Change of Control, which consent may be withheld in Licensor's sole discretion."
                            </div>
                        </div>
                    </div>
                </div>

                <div class="handoff">
                    <span class="handoff-arrow">‚Üí</span>
                    Requesting quantification from Financial Modeler
                </div>

                <!-- Financial Modeler quantifies -->
                <div class="thread-item">
                    <div class="thread-avatar financial">üí∞</div>
                    <div class="thread-content">
                        <div class="thread-header">
                            <span class="thread-agent">Financial Modeler</span>
                            <span class="thread-time">45 sec ago</span>
                        </div>
                        <span class="thread-action">IMPACT ANALYSIS</span>
                        <div class="thread-text">
                            Quantifying impact of Pfizer license termination:
                            <br><br>
                            ‚Ä¢ Annual royalty revenue: <strong>$180M</strong> (42% of total revenue)<br>
                            ‚Ä¢ NPV of future royalties: <strong>$1.2B</strong> (assuming 8-year remaining term)<br>
                            ‚Ä¢ Impact on enterprise value: <strong>-41%</strong> (from $890M to $520M)<br>
                            <br>
                            This is a <strong>deal-breaker level risk</strong>. Running Monte Carlo simulation...
                        </div>
                    </div>
                </div>

                <!-- Risk Assessor weighs in -->
                <div class="thread-item">
                    <div class="thread-avatar risk">‚ö†Ô∏è</div>
                    <div class="thread-content critical">
                        <div class="thread-header">
                            <span class="thread-agent">Risk Assessor</span>
                            <span class="thread-time">30 sec ago</span>
                        </div>
                        <span class="thread-action">RISK ESCALATION</span>
                        <div class="thread-text">
                            <strong>CRITICAL RISK IDENTIFIED</strong>
                            <br><br>
                            Cross-referencing with Section 7.4 reveals additional trigger: Pfizer can <strong>unilaterally terminate without liability</strong> if acquirer is on "Competing Company" list (Exhibit B).
                            <br><br>
                            I've checked Exhibit B ‚Äî it includes <strong>47 major pharma companies</strong> including most likely strategic acquirers.
                        </div>
                        <div class="evidence-card">
                            <div class="evidence-header">
                                üìÑ <span class="evidence-source">Pfizer_License_Agreement.pdf</span> ‚Ä¢ Exhibit B
                            </div>
                            <div class="evidence-quote">
                                Competing Companies include: Novartis, Roche, Merck, J&J, AbbVie, Bristol-Myers Squibb, AstraZeneca, GSK, Sanofi, Eli Lilly...
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Debate Section -->
                <div class="debate-section">
                    <div class="debate-header">
                        ‚ö° Agent Debate: Mitigation Strategy
                    </div>
                    <div class="debate-item">
                        <span class="debate-agent">Financial Modeler:</span> Recommend milestone-based earnout structure ‚Äî 40% contingent on Pfizer consent.
                    </div>
                    <div class="debate-item">
                        <span class="debate-agent">Contract Analyst:</span> Disagree. Better to make deal contingent on pre-close consent. Earnout doesn't protect against value destruction.
                    </div>
                    <div class="debate-item">
                        <span class="debate-agent">Risk Assessor:</span> Contract Analyst is correct. Historical data shows 73% of "sole discretion" clauses result in consent denial when acquirer is strategic competitor.
                    </div>
                </div>

                <!-- Consensus -->
                <div class="consensus-box">
                    <div class="consensus-header">
                        ‚úÖ Orchestrator ‚Äî CONSENSUS REACHED
                    </div>
                    <div class="consensus-content">
                        <strong>Recommendation:</strong> Make deal closing contingent on obtaining Pfizer written consent BEFORE signing definitive agreement. Do not proceed to LOI without informal Pfizer indication.
                        <br><br>
                        <strong>Supporting Evidence:</strong> 4 documents analyzed, 2 clauses identified, 1 financial scenario modeled
                        <br><br>
                        <strong>Alternative Considered:</strong> Milestone earnout structure (rejected due to insufficient downside protection)
                    </div>
                    <div class="consensus-confidence">
                        <span style="font-size: 0.8rem; color: var(--gray-600);">Confidence</span>
                        <div class="confidence-bar">
                            <div class="confidence-fill" style="width: 94%"></div>
                        </div>
                        <span class="confidence-value">94%</span>
                    </div>
                </div>
            </div>
        </main>

        <!-- Right: Question Panel -->
        <aside class="question-panel">
            <div class="question-header">
                <h3>Ask the Agents</h3>
                <p>Ask complex hypotheticals ‚Äî agents will reason together</p>
            </div>

            <div class="sample-questions">
                <div class="sample-label">Try asking</div>
                <button class="sample-btn">"What if Pfizer denies consent AND FDA rejects NP-201?"</button>
                <button class="sample-btn">"Are there any other contracts with similar provisions?"</button>
                <button class="sample-btn">"What's the probability Pfizer grants consent?"</button>
            </div>

            <div class="answer-history">
                <div class="answer-item">
                    <div class="answer-question">What other agreements have CoC provisions?</div>
                    <div class="answer-content">
                        <strong>3 additional agreements</strong> contain change-of-control provisions:
                        <br><br>
                        1. <strong>Merck Collaboration</strong> (¬ß4.2) ‚Äî 30-day notice, "reasonable" consent standard<br>
                        2. <strong>University of Penn License</strong> (¬ß8.1) ‚Äî No consent required, but royalty rate increases 2%<br>
                        3. <strong>Japanese Distribution</strong> (¬ß12.3) ‚Äî 60-day notice, consent not to be unreasonably withheld
                        <br><br>
                        Only Pfizer agreement has "sole discretion" standard. Others are manageable.
                    </div>
                    <div class="answer-meta">
                        <span>üìÑ 4 documents searched</span>
                        <span>ü§ñ 3 agents contributed</span>
                        <span>‚è±Ô∏è 12 sec</span>
                    </div>
                </div>
            </div>

            <div class="question-input-area">
                <div class="question-input">
                    <input type="text" placeholder="Ask a question about this deal...">
                    <button class="question-submit">‚Üí</button>
                </div>
            </div>
        </aside>
    </div>
</body>
</html>
